In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price target of $93.00. The company’s shares closed last Friday ...
Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Eli Lilly & Co, and AbbVie. According to TipRanks, Flynn has an average return of 12.6% and a 63.89% success rate on ...
EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...